Article Versions Notes

Rakic D, Jakovljevic V, Zivkovic V, Jakovljevic Uzelac J, Jovic N, Muric M, Pindovic B, Dimitrijevic A, Arsenijevic P, Rakic J, et al. Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model. Pathophysiology. 2024; 31(4):559-582. https://doi.org/10.3390/pathophysiology31040041

Rakic, Dejana, Vladimir Jakovljevic, Vladimir Zivkovic, Jovana Jakovljevic Uzelac, Nikola Jovic, Maja Muric, Bozidar Pindovic, Aleksandra Dimitrijevic, Petar Arsenijevic, Jovan Rakic, and et al. 2024. "Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model" Pathophysiology 31, no. 4: 559-582. https://doi.org/10.3390/pathophysiology31040041

Rakic, D., Jakovljevic, V., Zivkovic, V., Jakovljevic Uzelac, J., Jovic, N., Muric, M., Pindovic, B., Dimitrijevic, A., Arsenijevic, P., Rakic, J., Mitrovic, S., Vulovic, T., & Joksimovic Jovic, J. (2024). Multiple Benefits of Empagliflozin in PCOS: Evidence from a Preclinical Rat Model. Pathophysiology, 31(4), 559-582. https://doi.org/10.3390/pathophysiology31040041